Response To 1st-Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry »
04/09/14

The Incidence and Risk Factors For Hematological Malignancies and Premalignant Hematological Disorders In HIV. »
04/09/14

A Multicentre Retrospective UK Study Detailing Onset Of GvHD, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GvHD Are High But Death From GvHD Infrequent. »
04/09/14

Ibrutinib Inhibits B-Cell Adhesion and Causes An Efflux Of Chronic Lymphocytic Leukemia Cells From The Tissue Microenvironment Into The Blood Leading To a Transient Treatment-Induced Lymphocytosis. »
04/09/14

Outcomes Of Repeated Administration Of Rasburicase In Recurrent Cycles For Patients With Leukemia. »
04/09/14

Combination of the glycoengineered Type II CD20 antibody obinutuzumab (GA101) and The novel Bcl-2 selective Inhibitor GDC-0199 Results in superior In Vitro and In Vivo Anti-tumor activity in models Of B-Cell Malignancies »
04/09/14

Glycoengineered CD20 Antibody Obinutuzumab Activates Neutrophils and Mediates Phagocytosis Through CD16B More Efficiently Than Rituximab. »
04/09/14

Donor and Recipient STR Analysis Before Allogeneic Haematopoietic Stem Cell Transplantation: Possible Correlation With Post-Transplant Outcome »
04/09/14

Regulation Of Microrna Mir-21 Expression By ZAP-70 Protein In Chronic Lymphocytic Leukemia »
04/09/14

Thymidine Kinase Levels Correlate With Prognosis In High Grade Lymphoma, and Can Discriminate Patients With a Clinical Suspicion Of Low Grade To High Grade Transformation »
04/10/14